These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33275775)

  • 41. Micronutrient supplementation and pregnancy outcomes: double-blind randomized controlled trial in China.
    Liu JM; Mei Z; Ye R; Serdula MK; Ren A; Cogswell ME
    JAMA Intern Med; 2013 Feb; 173(4):276-82. PubMed ID: 23303315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin D supplementation for women during pregnancy.
    De-Regil LM; Palacios C; Lombardo LK; Peña-Rosas JP
    Cochrane Database Syst Rev; 2016 Jan; (1):CD008873. PubMed ID: 26765344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
    Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
    Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
    AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BRAzil magnesium (BRAMAG) trial: a double-masked randomized clinical trial of oral magnesium supplementation in pregnancy.
    de Araújo CAL; Ray JG; Figueiroa JN; Alves JG
    BMC Pregnancy Childbirth; 2020 Apr; 20(1):234. PubMed ID: 32316938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia.
    Liu KC; Farahani M; Mashamba T; Mawela M; Joseph J; Van Schaik N; Honey E; Gill M; Jassat W; Stringer EM; Chintu N; Marlink RG
    AIDS; 2014 Sep; 28(15):2259-68. PubMed ID: 25115319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out.
    González R; Rupérez M; Sevene E; Vala A; Maculuve S; Bulo H; Nhacolo A; Mayor A; Aponte JJ; Macete E; Menendez C
    PLoS One; 2017; 12(6):e0178134. PubMed ID: 28575010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.
    Conroy AL; McDonald CR; Gamble JL; Olwoch P; Natureeba P; Cohan D; Kamya MR; Havlir DV; Dorsey G; Kain KC
    Am J Obstet Gynecol; 2017 Dec; 217(6):684.e1-684.e17. PubMed ID: 29031892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.
    Lambert JS; Watts DH; Mofenson L; Stiehm ER; Harris DR; Bethel J; Whitehouse J; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H; van Dyke R; Maupin R; Silio M; Fowler MG
    AIDS; 2000 Jul; 14(10):1389-99. PubMed ID: 10930154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treating periodontal disease for preventing adverse birth outcomes in pregnant women.
    Iheozor-Ejiofor Z; Middleton P; Esposito M; Glenny AM
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005297. PubMed ID: 28605006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
    Joseph O; Biodun O; Michael E
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
    Kesho Bora Study Group
    Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
    N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermittent oral iron supplementation during pregnancy.
    Peña-Rosas JP; De-Regil LM; Gomez Malave H; Flores-Urrutia MC; Dowswell T
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009997. PubMed ID: 26482110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antenatal dietary education and supplementation to increase energy and protein intake.
    Ota E; Hori H; Mori R; Tobe-Gai R; Farrar D
    Cochrane Database Syst Rev; 2015 Jun; (6):CD000032. PubMed ID: 26031211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.
    Snijdewind IJM; Smit C; Godfried MH; Bakker R; Nellen JFJB; Jaddoe VWV; van Leeuwen E; Reiss P; Steegers EAP; van der Ende ME
    PLoS One; 2018; 13(1):e0191389. PubMed ID: 29351561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selenium supplementation and premature (pre-labour) rupture of membranes: a randomised double-blind placebo-controlled trial.
    Tara F; Rayman MP; Boskabadi H; Ghayour-Mobarhan M; Sahebkar A; Yazarlu O; Ouladan S; Tavallaie S; Azimi-Nezhad M; Shakeri MT; Teymoori MS; Razavi BS; Oladi M; Ferns G
    J Obstet Gynaecol; 2010 Jan; 30(1):30-4. PubMed ID: 20121500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of maternal human immunodeficiency virus infection on pregnancy and birth outcomes in Pune, India.
    Patil S; Bhosale R; Sambarey P; Gupte N; Suryavanshi N; Sastry J; Bollinger RC; Gupta A; Shankar A
    AIDS Care; 2011 Dec; 23(12):1562-9. PubMed ID: 21711178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.